Skip to main content
. 2021 Dec 9;3:783271. doi: 10.3389/frph.2021.783271

Table 2.

Outcomes and clinical characteristics of participants (N = 11).

Women's characteristics Prevalence, %*
Delays in days
Patient delay, median (IQR) 304 (183)
> 90 days, % (95% CI) 90.9 (58.7–99.8)
Healthcare delay, median (IQR) 61 (152)
> 90 days, % (95% CI) 45.4 (16.7–76.6)
Clinical characteristics
Histopathology
Squamous cell carcinoma 72.7
Adenocarcinoma 27.3
Cancer staging
II 45.4
III 18.2
IV 9.1
Unavailable 18.2
Signs and symptoms
Abnormal vaginal bleeding 90.9
Abnormal vaginal discharge 63.6
ower abdominal or back pain 63.6
Headache 45.4
Fatigue 36.4
Abdominal mass 18.2
Syncope 9.1
CC diagnosis
Biopsy 63.6
Imaging 18.2
Colposcopy 18.2
Treatment
Surgery (hysterectomy ± partial or total removal of annexes) 54.5
Surgery and chemotherapy 18.2
In planning at the time of data collection 27.3
Familiarity for cervical cancer 18.2
Comorbidities 18.2
Previous use of healthcare 18.2
Reasons for patient delay
(N = 10)
Unawareness of symptoms' seriousness 70.0
Unwillingness to consult healthcare professionals 30.0
Difficulty accessing healthcare 10.0
Mistreated by healthcare professionals at first visit 10.0
Prioritizing pressing family matters 10.0
Visiting more >1 healthcare professional before diagnosis 63.6
*

Percentages unless otherwise specified. FIGO (International Federation of Gynecologists and Obstetrics) 2018 staging classification (19). Comorbidities included self-reported major cardiovascular, respiratory, and kidney diseases, and cancer: in the present sample only two women reported having hypertension. IQR, inter-quartile range. CI, confidence intervals.